Delivery Order SPE2DB20D3103-SPE2DB23FP7G7
Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,209.66, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medications and medical supplies to various federal agencies, particularly the Department of Defense and the Department of...
- This federal contract award, valued at $2,848.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562829418 - ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product, with a performance period through November 16, 2023. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zonisade 100 mg/5 ml oral suspension, a pharmaceutical product, with a ceiling value of $1,546.43. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. The contract was awarded on April 14, 2025, and was not set aside...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a prescription medication. The $2,752.61 firm fixed price delivery order has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of medical commodities,...
- This federal contract award, valued at $11,573.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and facilities...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product, with a ceiling value of $1,122.49 and a period of performance through March 28, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,461.70 to AmerisourceBergen Drug Corp for the supply of Zonisade 100 mg/5 ml oral suspension in a 150 ml quantity. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX. The contract was competitively awarded with no...
- This federal contract award, valued at $2,543.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of 4564896600 - ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product, with a completion date of June 14, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $1,487.31 to supply 150ml of the oral suspension Zonisade 100 mg/5 ml. As the parent company, Amerisourcebergen Corporation will perform under the contract through its Corporate Office location in Conshohocken, Pennsylvania. The firm fixed price contract has an anticipated completion date of October 18, 2023 and did not utilize any set aside designations in the award. The Defense Logistics Agency supports...
- This federal contract award, with an ID of SPE2DB22D3011|SPE2DB24FQ0NN, was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,111.35 firm fixed price delivery order is for the supply of the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. The contract, which has an ultimate completion date of April 12, 2024, was awarded on April 11, 2024 by the Defense Logistics Agency (DLA), a defense...